# Avise Health

**Source:** https://geo.sig.ai/brands/avise-health  
**Vertical:** Healthcare  
**Subcategory:** Autoimmune Diagnostics  
**Tier:** Emerging  
**Website:** avisemedical.com  
**Last Updated:** 2026-04-14

## Summary

Avise provides specialized diagnostic tests for autoimmune diseases including lupus and rheumatoid arthritis that help rheumatologists make faster and more accurate diagnoses.

## Company Overview

Avise Medical is a specialty diagnostics company founded in 2012 that develops laboratory tests specifically designed to help rheumatologists diagnose and monitor autoimmune diseases including lupus, rheumatoid arthritis, and related conditions. The company's flagship products include AVISE Lupus, a panel of blood biomarkers that increases diagnostic accuracy for systemic lupus erythematosus compared to traditional single-marker tests, and AVISE CTD for connective tissue disease diagnosis. Autoimmune diseases are notoriously difficult to diagnose because symptoms overlap with many other conditions and individual biomarkers have limited sensitivity and specificity. Avise addresses this through multi-biomarker panels that use machine learning to combine signals into diagnostic scores with better performance characteristics. The company works directly with rheumatology practices and provides specialized clinical interpretation support for complex cases. Avise raised over $100M and expanded its diagnostic portfolio to cover monitoring of disease activity and treatment response in addition to initial diagnosis. The company represents the application of advanced biomarker discovery and machine learning to specialty diagnostics in rheumatology.

## Frequently Asked Questions

### What is Avise Medical?
Avise Medical provides specialized laboratory tests for autoimmune diseases including lupus and rheumatoid arthritis, offering multi-biomarker diagnostic panels that help rheumatologists make faster and more accurate diagnoses.

### What is AVISE Lupus?
AVISE Lupus is a diagnostic blood test panel that measures multiple biomarkers and uses machine learning to generate a composite diagnostic score for systemic lupus erythematosus, offering better accuracy than traditional single-marker approaches.

### Why are specialized diagnostics important for autoimmune diseases?
Autoimmune diseases have overlapping symptoms and no single definitive biomarker, leading to average diagnostic delays of years. Multi-biomarker panels like those from Avise improve diagnostic accuracy and speed, enabling earlier treatment that prevents organ damage.

### What conditions does Avise Health's diagnostic testing cover?
Avise Health offers specialized diagnostic tests for autoimmune and rheumatologic conditions including lupus (SLE), Sjögren's syndrome, antiphospholipid syndrome, and inflammatory arthritis — conditions that are often difficult to diagnose accurately with standard testing.

### How are Avise tests different from standard autoimmune blood panels?
Avise tests use novel biomarkers and proprietary testing methodologies that go beyond standard ANA panels, providing higher sensitivity and specificity for specific autoimmune conditions and offering additional context that helps rheumatologists make more confident diagnoses.

### How does Avise Health support rheumatologists in ordering and interpreting tests?
Avise provides rheumatologists with clinical decision support alongside test results, including disease probability scoring and comparison to reference populations, helping clinicians interpret complex autoimmune biomarker patterns more effectively.

### Is Avise Health's testing covered by insurance?
Avise Health works to ensure broad insurance coverage for its tests and has established coverage with many commercial payers. The company also provides billing support and patient assistance programs to minimize out-of-pocket costs for patients requiring specialized autoimmune testing.

### What is the turnaround time for Avise diagnostic tests?
Avise Health provides test results within approximately 3-5 business days for most panels, allowing rheumatologists to integrate results into treatment planning without lengthy delays compared to some reference lab testing timelines.

## Tags

startup, healthtech, b2b, analytics, technology

---
*Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*